Premier Alternatives

General Proximity

San Francisco, CA · Founded 2019 · Privately Held (backing)

Operator of a biotech company intended to develop drugs that activate existing cellular machinery. General Proximity is based in San Francisco, CA and was founded in 2019. Its last reported valuation was $2.1 million in Jan 2020. It has raised $16.1 million.

Last reported valuation
$2.1M
Oct 2026
Priced at
—
Total raised
$16.1M
Last round
—

General Proximity key facts

as of Oct 2026
  • Operator of a biotech company intended to develop drugs that activate existing cellular machinery.
  • General Proximity is valued at approximately $2.1M as of Oct 2026 (last reported valuation).
  • It has raised $16.1M; the latest was Later Stage VC ($16.0M) in Dec 2024.
  • Notable investors include Y Combinator, Mana Ventures, Bossa Invest, Felicis, Jeff Dean — 26 tracked in total.
  • 1 investment vehicle was formed to buy General Proximity shares in the last 12 months, reporting $276K sold to 14 investors, per SEC Form D filings.
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$2.1M

General Proximity's last reported valuation, Jan 2020. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of General Proximity with a free account
  • ·The complete investor list: 26 names
  • ·Watch General Proximity: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

General Proximity funding rounds

No rounds on record

No funding rounds for General Proximity are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Vehicles formed to buy General Proximity shares

secondary demand · SEC Form D filings

In the last 12 months, 1 investment vehicle were formed to buy General Proximity shares, reporting $276K sold to 14 investors. Most recent filing Apr 2026.

The vehicle list — each sponsor, filing date, amount sold and investor count — is a Pro table. Unlock the 1 vehicle →

Membership and data by Private Market View

Companies with the most vehicle activity →

General Proximity valuation

General Proximity's last reported valuation was $2.1 million in Jan 2020. No priced round, secondary trade or fund mark has surfaced since.

Institutional holders and vehicles

In the last 12 months, 1 investment vehicle was formed to buy General Proximity shares, reporting $276,250 sold to 14 investors, per SEC Form D filings (most recent Apr 2026).

General Proximity investors

26 investors are on record for General Proximity, including Y Combinator, Mana Ventures, Bossa Invest and Felicis. By type, the record holds 5 venture capital firms and 1 angel investor.

About General Proximity

Operator of a biotech company intended to develop drugs that activate existing cellular machinery. The company produces the next generation of induced-proximity medicines, enabling doctors to treat harmful human diseases.

Sector
Healthcare
HQ
San Francisco, CA, United States
Founded
2019
Employees
21
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.